A Case of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Treated by Hepatic Arterial Infusion Chemotherapy and Radiotherapy

Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT). Additionally, hepatic arterial infusion chemotherapy has been used as a treatment option for advanced HCC. Here, we report a case of sustained partial response in a patient with advance...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jin Yong, Yoo, Jeong-Ju, Chun, Seong Joon, Bae, Sun Hyun, Lee, Jae Myeong, Kim, Sang Gyune, Kim, Young Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Liver Cancer Association 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035700/
https://www.ncbi.nlm.nih.gov/pubmed/37383060
http://dx.doi.org/10.17998/jlc.20.1.78
Descripción
Sumario:Sorafenib is the standard treatment for advanced hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT). Additionally, hepatic arterial infusion chemotherapy has been used as a treatment option for advanced HCC. Here, we report a case of sustained partial response in a patient with advanced HCC with PVT after hepatic arterial infusion chemotherapy and radiation therapy.

Ejemplares similares